NCT00599846终止不适用
The Natural History of Geographic Atrophy Progression (GAP) Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- GA progression rate using fundus autofluorescence
研究概览
简要总结
The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of geographic atrophy secondary to age-related macular degeneration with no CNV lesion.
排除标准
- •Age related
结局指标
主要结局
GA progression rate using fundus autofluorescence
时间窗: From baseline
次要结局
- GA progression rate using fundus photography(From baseline)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD PatientsAge-Related Macular DegenerationNCT02130024Novartis Pharmaceuticals281
已完成
2 期
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic AtrophyGeographic AtrophyNCT04656561Annexon, Inc.270
招募中
不适用
Natural History Study of Children With LAMA2-related DystrophiesMerosin Deficient Congenital Muscular DystrophyNCT06354790Institut de Myologie, France40
进行中（未招募）
2 期
A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyGeographic AtrophyNCT06769048Boehringer Ingelheim150
已完成
不适用
Evolution and Risk Factors Associated With Geographic Atrophy ProgressionGeographic AtrophyNCT01694095Institut de la Macula y la Retina96